Cargando…
PDRG1 at the interface between intermediary metabolism and oncogenesis
PDRG1 is a small oncogenic protein of 133 residues. In normal human tissues, the p53 and DNA damage-regulated gene 1 (PDRG1) gene exhibits maximal expression in the testis and minimal levels in the liver. Increased expression has been detected in several tumor cells and in response to genotoxic stre...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714802/ https://www.ncbi.nlm.nih.gov/pubmed/29225734 http://dx.doi.org/10.4331/wjbc.v8.i4.175 |
_version_ | 1783283634603556864 |
---|---|
author | Pajares, María Ángeles |
author_facet | Pajares, María Ángeles |
author_sort | Pajares, María Ángeles |
collection | PubMed |
description | PDRG1 is a small oncogenic protein of 133 residues. In normal human tissues, the p53 and DNA damage-regulated gene 1 (PDRG1) gene exhibits maximal expression in the testis and minimal levels in the liver. Increased expression has been detected in several tumor cells and in response to genotoxic stress. High-throughput studies identified the PDRG1 protein in a variety of macromolecular complexes involved in processes that are altered in cancer cells. For example, this oncogene has been found as part of the RNA polymerase II complex, the splicing machinery and nutrient sensing machinery, although its role in these complexes remains unclear. More recently, the PDRG1 protein was found as an interaction target for the catalytic subunits of methionine adenosyltransferases. These enzymes synthesize S-adenosylmethionine, the methyl donor for, among others, epigenetic methylations that occur on the DNA and histones. In fact, downregulation of S-adenosylmethionine synthesis is the first functional effect directly ascribed to PDRG1. The existence of global DNA hypomethylation, together with increased PDRG1 expression, in many tumor cells highlights the importance of this interaction as one of the putative underlying causes for cell transformation. Here, we will review the accumulated knowledge on this oncogene, emphasizing the numerous aspects that remain to be explored. |
format | Online Article Text |
id | pubmed-5714802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-57148022017-12-08 PDRG1 at the interface between intermediary metabolism and oncogenesis Pajares, María Ángeles World J Biol Chem Minireviews PDRG1 is a small oncogenic protein of 133 residues. In normal human tissues, the p53 and DNA damage-regulated gene 1 (PDRG1) gene exhibits maximal expression in the testis and minimal levels in the liver. Increased expression has been detected in several tumor cells and in response to genotoxic stress. High-throughput studies identified the PDRG1 protein in a variety of macromolecular complexes involved in processes that are altered in cancer cells. For example, this oncogene has been found as part of the RNA polymerase II complex, the splicing machinery and nutrient sensing machinery, although its role in these complexes remains unclear. More recently, the PDRG1 protein was found as an interaction target for the catalytic subunits of methionine adenosyltransferases. These enzymes synthesize S-adenosylmethionine, the methyl donor for, among others, epigenetic methylations that occur on the DNA and histones. In fact, downregulation of S-adenosylmethionine synthesis is the first functional effect directly ascribed to PDRG1. The existence of global DNA hypomethylation, together with increased PDRG1 expression, in many tumor cells highlights the importance of this interaction as one of the putative underlying causes for cell transformation. Here, we will review the accumulated knowledge on this oncogene, emphasizing the numerous aspects that remain to be explored. Baishideng Publishing Group Inc 2017-11-26 2017-11-26 /pmc/articles/PMC5714802/ /pubmed/29225734 http://dx.doi.org/10.4331/wjbc.v8.i4.175 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Minireviews Pajares, María Ángeles PDRG1 at the interface between intermediary metabolism and oncogenesis |
title | PDRG1 at the interface between intermediary metabolism and oncogenesis |
title_full | PDRG1 at the interface between intermediary metabolism and oncogenesis |
title_fullStr | PDRG1 at the interface between intermediary metabolism and oncogenesis |
title_full_unstemmed | PDRG1 at the interface between intermediary metabolism and oncogenesis |
title_short | PDRG1 at the interface between intermediary metabolism and oncogenesis |
title_sort | pdrg1 at the interface between intermediary metabolism and oncogenesis |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714802/ https://www.ncbi.nlm.nih.gov/pubmed/29225734 http://dx.doi.org/10.4331/wjbc.v8.i4.175 |
work_keys_str_mv | AT pajaresmariaangeles pdrg1attheinterfacebetweenintermediarymetabolismandoncogenesis |